White C J, Ramee S R, Collins T J, Murgo J P
Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana 70121, USA.
Tex Heart Inst J. 1995;22(1):20-5.
Coronary angioscopy will not replace angiography as the gold standard for imaging atherosclerotic coronary arteries. However, there may well be a clinical niche for a technology that gives accurate information regarding a specific lesion, if that information can be used to improve the acute or chronic outcome of an interventional procedure. Our experience demonstrates that angioscopy indeed provides this information. Using angioscopy, we now have access to information regarding arterial wall disease that heretofore has been available only at necropsy. In addition, whereas angiography has provided only a 2-dimensional, gray-scale image of the coronary vessels, angioscopy offers a full-color, 3-dimensional perspective of the intracoronary surface morphology. These important lesion-specific details, not reliably available from angiography alone, may ultimately be used to improve patient outcome and to assess risk.
冠状动脉血管镜不会取代血管造影术成为成像动脉粥样硬化冠状动脉的金标准。然而,如果一项技术能够提供有关特定病变的准确信息,并且该信息可用于改善介入手术的急性或慢性结果,那么这项技术很可能在临床上占有一席之地。我们的经验表明,血管镜确实能提供此类信息。通过血管镜,我们现在能够获取有关动脉壁疾病的信息,而这些信息此前只能在尸检时获得。此外,血管造影术仅提供冠状动脉血管的二维灰度图像,而血管镜则能提供冠状动脉内表面形态的全彩色三维视角。这些重要的病变特异性细节,仅靠血管造影术无法可靠获取,最终可能用于改善患者预后并评估风险。